Bnp Paribas Arbitrage, Snc »

Acasti Pharma shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Acasti Pharma (GRCE) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Acasti Pharma

Tip: Access up to 7 years of quarterly data

All positions including Acasti Pharma held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acasti Pharma by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.1k 600 3.46

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Apple Equity (AAPL)
Amazon.com Equity (AMZN)
Meta Platforms Equity (META)
Tesla Equity (TSLA)
Alphabet Equity (GOOGL)
JPMorgan Chase & Co Equity (JPM)
Broadcom Equity (AVGO)
State Street SPDR S&P Biotech ETF Fund (XBI)
Alphabet Equity (GOOG)
State Street SPDR S&P 500 ETF Trust Fund (SPY)
Cisco Systems Equity (CSCO)
Micron Technology Equity (MU)
Advanced Micro Devices Equity (AMD)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Acasti Pharma

Nantahala Capital Management
AIGH Capital Management
ADAR1 Capital Management
Vanguard Group
HPM Partners
Renaissance Technologies
XTX Topco
Citadel Advisors
GSA Capital Partners
Stratos Wealth Partners
National Bank Of Canada /fi/
Tower Research Capital
Bnp Paribas Arbitrage, Snc
Royal Bank of Canada
Activest Wealth Management

View all funds holding Acasti Pharma